USPTO serial 98294206
IMOTOPE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 29, 2024
- Examiner
- SPRUILL, DARRYL M
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with IMOTOPE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Angleur, BE
Angleur, BE
Angleur, BE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Martin W. Schiffmiller
Martin W. Schiffmiller Kirschstein Israel Schiffmiller & Pieroni, P.C.66 Palmer Avenue, Suite 49BBronxville, NY 10708United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products for use in the treatment and prevention of autoimmune diseases, infectious diseases, cancer, multiple sclerosis, type 1 diabetes, myasthenia gravis, rheumatoid arthritis and viral diseases, allergies, celiac disease and immune responses against allofactors used for therapy, viral vectors used for gene therapy or gene vaccination and autoimmune responses to organ or cellular transplantation; veterinary preparations for mammals for use in the treatment and prevention of autoimmune diseases, infectious diseases and cancer; vaccines; vaccine preparations for human or veterinary use | ACTIVE | — |
| 042 | Scientific and technological services, namely, scientific research, analysis and design in the fields of immunology, chronic diseases, infectious diseases, cancer and regeneration of damaged organs; industrial research and analysis in the fields of immunology, chronic diseases, infectious diseases, cancer and regeneration of damaged organs; research and development of vaccines and medicines | ACTIVE | — |
| 044 | Medical services; veterinary services; hygienic and beauty care for human beings and animals; providing medical information concerning vaccination | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 29, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 29, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 13, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 13, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 24, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 2, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 1, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 1, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 1, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 30, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 30, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 30, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 28, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 25, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 1, 2023 | NWAP | NEW APPLICATION ENTERED | — |